← Eichor
Condition: Antiphospholipid Syndrome Aps Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Antiphospholipid Syndrome Aps

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Anifrolumab in Adults With Primary Antiphospholipid Syndrome (AnifAPS Trial)
Phase 2 · 1 location(s) · National and Kapodistrian University of Athens · NCT07584083Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Phase 1 · 77 location(s) · Chugai Pharmaceutical · NCT06371417A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
Phase 1 · 1 location(s) · China Immunotech (Beijing) Biotechnology Co., Ltd. · NCT07104721A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases
Phase 1 · 1 location(s) · China Immunotech (Beijing) Biotechnology Co., Ltd. · NCT06978647Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS
Phase N/A · 3 location(s) · McMaster University · NCT05646394International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants
Phase N/A · 1 location(s) · Stéphane Zuily · NCT04262492Anti-CD38 Antibody Treating APS With Thrombocytopenia
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT05983952Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study
Phase N/A · 1 location(s) · University of California, Davis · NCT00616317Observational Study to Evaluate the Effectiveness of DOACS for Secondary Thrombosis Prevention in Low-risk Thrombotic AP
Phase N/A · 2 location(s) · Infanta Leonor University Hospital · NCT07372170Follow-up Cohort of Patients With Antiphospholipid Syndrome
Phase N/A · 1 location(s) · University Hospital, Rouen · NCT07178925Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases
Phase N/A · 6 location(s) · Santé Arménie French-Armenian Research Center · NCT05904301A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases
Phase 1 · 1 location(s) · China Immunotech (Beijing) Biotechnology Co., Ltd. · NCT07123519Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin As Secondary Prevention Strategy for AntiPhospholip
Phase 4 · 32 location(s) · Seoul National University Hospital · NCT05995600IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Phase 2 · 3 location(s) · David Ware Branch · NCT03152058Effect of Belimumab on Antibody Titers in Primary APS Patients
Phase 2 · 1 location(s) · Ruijin Hospital · NCT06747312Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
Phase N/A · 10 location(s) · Hospital for Special Surgery, New York · NCT00198068
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.